Source link : https://newshealth.biz/health-news/sotagliflozin-lowers-a1c-weight-even-in-kidney-impairment/
ORLANDO, Florida — Sotagliflozin (Inpefa) reduces A1c and body weight in people with type 2 diabetes, although the degree of improvement was attenuated in those with moderate-to-severe chronic kidney disease (CKD). “These findings highlight the importance of considering the effect of kidney function to help inform and tailor treatment decision-making for patients with diabetes and […]
The post Sotagliflozin Lowers A1c, Weight Even in Kidney Impairment first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-17 14:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8